Literature DB >> 33798632

Contribution of the tumor and obese microenvironment to triple negative breast cancer.

Kirti Kaul1, Swati Misri2, Bhuvaneswari Ramaswamy3, Ramesh K Ganju4.   

Abstract

The growing burden of obesity and incidence of the aggressive triple negative breast cancer (TNBC) is a challenge, especially amongst vulnerable populations with unmet medical needs and higher mortality from breast cancer. While some mechanisms linking obesity and TNBC have been identified, the complex nature of pathogenesis, in both obesity as well as TNBC poses a real challenge in establishing a causative role of obesity in risk of TNBC. In this review article, we discuss pathological mechanisms identified in the tumor microenvironment (TME) as well as the obese microenvironment (OME), such as inflammation, insulin resistance and survival pathways that contribute to the development and progression of TNBC. Insights into the cross-talk between TME and OME, and their contribution to TNBC development and progression, may pave the way for personalized therapies against TNBC progression, relapse and metastasis.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Immunotherapy; Obese microenvironment; Obesity; Triple negative breast cancer; Tumor microenvironment

Year:  2021        PMID: 33798632     DOI: 10.1016/j.canlet.2021.03.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer.

Authors:  Lin Ang; Jiang Li; Hui Dong; Chunhong Wang; Jin Huang; Mingcong Li; Min Zhao; Changqing Su; Qiang Wu
Journal:  Bioengineering (Basel)       Date:  2022-07-26

2.  14-weeks combined exercise epigenetically modulated 118 genes of menopausal women with prediabetes.

Authors:  Natália Yumi Noronha; Guilherme da Silva Rodrigues; Isabella Harumi Yonehara Noma; Camila Fernanda Cunha Brandao; Karine Pereira Rodrigues; Alexandre Colello Bruno; Chanachai Sae-Lee; Lígia Moriguchi Watanabe; Marcela Augusta de Souza Pinhel; Isabelle Mello Schineider; Mariana Luciano de Almeida; Fernando Barbosa Júnior; Déborah Araújo Morais; Wellington Tavares de Sousa Júnior; Torsten Plösch; Carlos Roberto Bueno Junior; Carla Barbosa Nonino
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-15       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.